Profile: Carl Zeiss Meditec, Inc. supplies complete system solutions in the field of medical technology for ophthalmology. We offer a full complement of synergistic technologies for the detection & quantifiable analysis of both structural and functional glaucomatous damage. Our stratus OCT incorporates optical coherence tomography technology to provide comprehensive imaging and measurement of glaucoma & retinal disease.
The company was founded in 2000, has revenues of < USD 1 Million, has ~2100 employees and is ISO 9000, ISO 9001, CE certified. ETR:AFX (SEC Filings)
FDA Registration Number: 2918630